Concord Well being Basis has secured a contract with the Tennessee Division of Mental and Developmental Disabilities that marks the beginning of a journey in the direction of increasing entry to healthcare for underserved communities.
The contract alternative issued by the Tennessee Division of Normal Companies sought companions with specialised experience in dental expertise to offer session providers for people with mental and developmental disabilities (I/DD).
People with I/DD have restricted entry to preventive dental providers, leading to greater charges of untreated dental situations and poorer oral well being outcomes. An ongoing dental healthcare workforce disaster is exacerbating entry to take care of the I/DD inhabitants, resulting in lengthy wait occasions and challenges to handle essential dental wants.
The mission has the potential to facilitate preventive care at house for people dealing with limitations to accessing conventional healthcare through the use of Oral Genome’s point-of-care saliva assessments. Concord Well being Basis may also work with the American Institute of Dental Public Well being, a pacesetter in advancing equitable oral well being coverage, to conduct community-engaged analysis and workforce training.
“Oral well being is essential to the general well being and well-being of all individuals, together with individuals with mental and developmental disabilities,” mentioned DIDD Commissioner Brad Turner. “I’m hopeful this partnership will empower individuals with disabilities and their supporters to higher handle at-home dental wants with new instruments and improve training in regards to the significance of preventative care.”
Concord Well being Basis is happy in regards to the alternative to positively affect the oral well being and well-being of people with mental and developmental disabilities in Tennessee.
Gratia Well being, a 25m Well being portfolio firm, has emerged from stealth with seed funding led by JumpStart Capital, and a contract with strategic companion, ScionHealth, to implement its incentive compensation platform throughout the well being system’s 76 specialty hospitals, in response to a press launch.
Gratia Well being’s tech-enabled worker incentive platform for caregivers who decide up work shifts on the firm’s 76 specialty hospitals. Eligible workers can use the tech to seek out and safe further shifts whereas monitoring their progress towards pay incentives and standing rewards that assist caregivers attain private earnings objectives.
25m Well being is a thesis-driven healthtech Enterprise Studio constructing and investing in new corporations within the digital well being area with a pointy concentrate on B2B healthcare IT and B2B2C tech-enabled care supply.
To learn extra, click on right here.
Pathway, an AI-driven medical data platform, has secured $5 million in seed funding to advance its options to data overload amongst healthcare professionals. Pathway creates concise summaries from follow steering derived from hundreds of thousands of evidence-based sources, serving to clinicians keep up-to-date and supply environment friendly, high-quality care, in response to a press launch.
Yamaha Motor Ventures led the spherical, joined by Verge HealthTech Fund, with participation from present traders Amplify Capital, BoxOne Ventures, and Formentera Capital. The spherical additionally obtained the backing of a number of physicians who’ve skilled the advantages and transformative potential of Pathway firsthand, the discharge mentioned.
Jonathan Hershon, CEO of Pathway mentioned the funding will speed up the rollout of Pathway’s expertise and amplify its attain to clinicians.
To be taught extra, click on right here.
Fortuna Well being, a consumer-facing platform simplifying Medicaid navigation, has obtained a seed funding of $4 million led by Andreessen Horowitz (a16z) Bio + Well being with participation from BoxGroup and Y Combinator. The funding accelerates Fortuna’s state enlargement and partnerships with managed care organizations (MCOs), well being techniques, and repair suppliers within the Medicaid area, in response to a press launch.
Fortuna’s self-serve platform is designed to eradicate the necessity to work together with state portals and bodily types. It claims to display screen for Medicaid eligibility in below 60 seconds with quick enrollment and recertification in additional than seven languages. To speed up software completion, customers can join third-party accounts to populate type fields, photograph add paperwork, and obtain textual content/electronic mail notifications for pressing actions. Fortuna offers extra reside help from licensed navigators as wanted.
Moreover, a number of angel traders and advisers took half within the seed spherical together with: Jeff Sachs (CEO, Sachs Coverage Group), Cyrus Massoumi (founder, Zocdoc), Jeff Gerard (former President, Sutter Well being Bay Space), Elliot Cohen (Founder, PillPack), Iyah and Sylvia Romm (Founder and former Chief Well being Officer, Cityblock), Ellen DaSilva (Founder, Summer season Well being), in addition to EGOT winner, entrepreneur, and social advocate John Legend who got here into the spherical via help from a16z’s Cultural Management Fund.
To learn extra, click on right here.
1910 Genetics, a biotech utilizing with an automatic, multimodal AI platform to advance small and enormous molecule drug discovery, has named Bridget Cole Chief Scientific Officer. Cole beforehand served as SVP and Head of Chemistry. She is going to lead the biotech’s scientific analysis operations, set and advance analysis priorities, and work intently with 1910’s AI management to information mannequin and platform growth together with her drug growth experience.
“Our ambition to generate small and enormous molecule medication, utilizing a multimodal AI and data-intensive platform, requires a seasoned however progressive drug developer and crew chief like Bridget,” mentioned Jen Nwankwo, founder and CEO. “As Chief Scientific Officer, Bridget will take over extra analysis obligations internally and externally, interact immediately with companions on scientific R&D, and help our imaginative and prescient to develop into the following Genentech – a real innovator in advancing trendy drug discovery.”
To be taught extra, click on right here.
Image: akindo, Getty Photos
